文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

重症新型冠状病毒病2019患者重叠感染的流行病学与临床特征

Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients.
PubMed 文献 · Crit Care Explor · 2021-06-11
一句话结论需机械通气的COVID-19 ARDS患者ICU期间重叠感染发生率高(57.6%),细菌重叠感染与ICU或28天死亡独立相关(OR 10.53)。

该研究为前瞻性收集数据的回顾性分析,纳入2020年2月21日至5月6日大学附属成人ICU收治的92例COVID-19患者,描述重叠感染(入院>48小时后发生)的流行病学及其对ICU和28天死亡率的影响。ICU入住时重叠感染患病率为21.7%,53例(57.6%)在ICU期间至少发生一次重叠感染,包括75例(82%)呼吸机相关性肺炎和57例(62%)系统性感染。细菌感染(OR 10.53;95%CI 2.31-63.42;p=0.005)、年龄(OR 1.17;95%CI 1.07-1.31;p=0.001)和最高SOFA评分(OR 1.27;95%CI 1.06-1.63;p=0.032)与ICU或28天死亡独立相关。

要点

  • ICU期间57.6%(53例)的COVID-19机械通气患者发生至少一次重叠感染,ICU入住时患病率为21.7%。
  • 呼吸机相关性肺炎75例(82%),最常见病原为铜绿假单胞菌(26例,34.7%)和嗜麦芽窄食单胞菌(14例,18.7%)。
  • 血流感染16例,包括耐甲氧西林表皮葡萄球菌(8例,14.0%)、肠球菌属(6例,10.5%)和链球菌属(2例,3.5%)。
  • 真菌感染41例,其中36例为很可能侵袭性念珠菌病(30例白念珠菌、6例非白念珠菌),5例为确诊侵袭性念珠菌病(3例白念珠菌、2例非白念珠菌)。
  • 细菌感染(OR 10.53;95%CI 2.31-63.42;p=0.005)、年龄(OR 1.17;95%CI 1.07-1.31;p=0.001)和最高SOFA评分(OR 1.27;95%CI 1.06-1.63;p=0.032)与ICU或28天死亡独立相关。

适用人群与场景

  • 2020年2月21日至2020年5月6日入住大学附属成人ICU的92例COVID-19合并ARDS需机械通气的患者。

研究设计与关键结果

  • 研究类型:前瞻性收集数据的回顾性分析;样本量92例;单中心大学附属成人ICU;人群为COVID-19合并ARDS需机械通气的患者;无干预。
  • 主要结果:ICU入住时重叠感染(入院>48小时后发生)患病率21.7%;53例(57.6%)在ICU期间至少发生一次重叠感染;呼吸机相关性肺炎75例(82%),系统性感染57例(62%)。
  • 呼吸机相关性肺炎病原:铜绿假单胞菌26例(34.7%)、嗜麦芽窄食单胞菌14例(18.7%)。
  • 血流感染16例:耐甲氧西林表皮葡萄球菌8例(14.0%)、肠球菌属6例(10.5%)、链球菌属2例(3.5%)。
  • 真菌感染41例:很可能36例(白念珠菌30例、非白念珠菌6例),确诊侵袭性念珠菌病5例(白念珠菌3例、非白念珠菌2例)。
  • 多因素分析:细菌感染(OR 10.53;95%CI 2.31-63.42;p=0.005)、年龄(OR 1.17;95%CI 1.07-1.31;p=0.001)、最高SOFA评分(OR 1.27;95%CI 1.06-1.63;p=0.032)与ICU或28天死亡独立相关。

证据类型、等级与局限

  • 证据类型:前瞻性收集数据的回顾性分析;单中心;样本量92例;原文未报告证据等级;局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,本系列需机械通气的COVID-19患者重叠感染患病率高,细菌重叠感染与ICU或28天死亡独立相关(OR 10.53;95%CI 2.31-63.42;p=0.005)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: To describe the epidemiology of superinfections (occurring > 48 hr after hospital admission) and their impact on the ICU and 28-day mortality in patients with coronavirus disease 2019 with acute respiratory distress syndrome, requiring mechanical ventilation.

DESIGN: Retrospective analysis of prospectively collected observational data.

SETTING: University-affiliated adult ICU.

PATIENTS: Ninety-two coronavirus disease 2019 patients admitted to the ICU from February 21, 2020, to May 6, 2020.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: The prevalence of superinfection at ICU admission was 21.7%, and 53 patients (57.6%) had at least one superinfection during ICU stay, with a total of 75 (82%) ventilator-associated pneumonia and 57 (62%) systemic infections. The most common pathogens responsible for ventilator-associated pneumonia were Pseudomonas aeruginosa (n = 26, 34.7%) and Stenotrophomonas maltophilia (n = 14, 18.7%). Bloodstream infection occurred in 16 cases, including methicillin-resistant Staphylococcus epidermidis (n = 8, 14.0%), Enterococcus species (n = 6, 10.5%), and Streptococcus species (n = 2, 3.5%). Fungal infections occurred in 41 cases, including 36 probable (30 by Candida albicans, six by C. nonalbicans) and five proven invasive candidiasis (three C. albicans, two C. nonalbicans). Presence of bacterial infections (odds ratio, 10.53; 95% CI, 2.31-63.42; p = 0.005), age (odds ratio, 1.17; 95% CI, 1.07-1.31; p = 0.001), and the highest Sequential Organ Failure Assessment score (odds ratio, 1.27; 95% CI, 1.06-1.63; p = 0.032) were independently associated with ICU or 28-day mortality.

CONCLUSIONS: Prevalence of superinfections in coronavirus disease 2019 patients requiring mechanical ventilation was high in this series, and bacterial superinfections were independently associated with ICU or 28-day mortality (whichever comes first).

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Signorini L, Moioli G, Calza S, et al. Epidemiological and Clinical Characterization of Superinfections in Critically Ill Coronavirus Disease 2019 Patients. Crit Care Explor. 2021. PMID: 34136819. doi:10.1097/CCE.0000000000000430

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。